Clinical Trials: Immunotoxins and Mesothelioma
Key takeaways: Immunotoxins are immune cells that have been chemically bound to toxicchemicals. These immune cells are able to target specific cells—in this case, mesothelioma cellsby way of mesothelin—and kill them. LMB-100 is a mesothelin-targeting immunotoxictreatment that successfully completed clinical trials. Immunotoxins like LMB-100 aren’t yet awidespread means of treatment, but their success is promising. […]
